A detailed history of Virtu Financial LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 30,112 shares of CAPR stock, worth $556,770. This represents 0.03% of its overall portfolio holdings.

Number of Shares
30,112
Holding current value
$556,770
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$3.56 - $15.21 $107,198 - $458,003
30,112 New
30,112 $458,000
Q1 2023

May 01, 2023

BUY
$3.78 - $5.03 $63,863 - $84,981
16,895 New
16,895 $71,000
Q4 2021

Feb 17, 2022

SELL
$2.89 - $4.16 $159,528 - $229,632
-55,200 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$3.8 - $5.23 $209,760 - $288,696
55,200 New
55,200 $222,000
Q3 2020

Dec 11, 2020

SELL
$4.08 - $9.81 $234,371 - $563,525
-57,444 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$1.0 - $8.5 $57,444 - $488,274
57,444 New
57,444 $264,000

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $450M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.